Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.
The international epidemiology of disseminated Mycobacterium avium complex infection in AIDS. International MAC Study Group.
AIDS. 1996 Aug;10(9):1025-32. Unique Identifier : AIDSLINE MED/97006444 Fordham von Reyn C; Arbeit RD; Tosteson AN; Ristola MA; Barber TW; Waddell R; Sox CH; Brindle RJ; Gilks CF; Ranki A; Bartholomew C; Edwards J; Falkinham JO 3rd; O'Connor GT; Infectious Disease Section, Dartmouth-Hitchcock Medical Center,; Lebanon, New Hampshire 03756, USA.
Abstract:
OBJECTIVE: To determine rates of disseminated Mycobacterium avium complex (MAC) infection among AIDS patients in developed and developing countries, and to determine whether different rates reflect differences in exposure or immunity, or both. DESIGN: Prospective cohort study. SETTING: University hospitals and outpatient AIDS programs. METHODS: HIV-infected subjects with CD4 counts < 200 x 10(6)/l were interviewed and had CD4 lymphocyte counts, blood cultures for mycobacteria (baseline and at 6 months), and skin tests with purified protein derivative (PPD) and M. avium sensitin. RESULTS: Among 566 study patients rates of disseminated MAC were 10.5-21.6% in New Hampshire, Boston and Finland compared to 2.4-2.6% in Trinidad and Kenya (P < 0.001). PPD skin test reactions > or = 5 mm were present in 20% of patients from Kenya compared to 1% at other sites (P < 0.001). Among patients from the United States and Finland, multiple logistic regression indicated that occupational exposure to soil and water was associated with a decreased risk of disseminated MAC, whereas the following were associated with an increased risk of disseminated MAC: low CD4 count, swimming in an indoor pool, history of bronchoscopy, regular consumption of raw or partially cooked fish/shellfish and treatment with granulocyte colony-stimulating factor. CONCLUSIONS: Rates of disseminated MAC in AIDS are higher in developed than developing countries and are due to both differences in exposure and differences in immunity. These data provide a rationale for prevention of MAC through both active immunization and reduction in exposure to the organism.
Keywords: Academic Medical Centers Adolescence Adult Aged AIDS-Related Opportunistic Infections/*EPIDEMIOLOGY Cohort Studies Finland/EPIDEMIOLOGY Human Kenya/EPIDEMIOLOGY Middle Age Multivariate Analysis Mycobacterium avium/*ISOLATION & PURIF Prospective Studies Risk Factors Support, U.S. Gov't, P.H.S. Trinidad and Tobago/EPIDEMIOLOGY Tuberculosis/*EPIDEMIOLOGY/ETIOLOGY JOURNAL ARTICLE MULTICENTER STUDY 970330
M9731519
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.